FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023246576> ?p ?o ?g. }

• W2023246576 endingPage "2415" @default.
• W2023246576 startingPage "2408" @default.
• W2023246576 abstract "We previously investigated the potential of targeted radiotherapy using a bismuth-213 ((213)Bi)-labeled anti-CD45 antibody to replace total body irradiation as conditioning for hematopoietic cell transplantation in a canine model. Although this approach allowed sustained marrow engraftment, limited availability, high cost, and short half-life of (213)Bi induced us to investigate an alternative alpha-emitting radionuclide, astatine-211 ((211)At), for the same application. Biodistribution and toxicity studies were conducted with conjugates of the anti-murine CD45 antibody 30F11 with either (213)Bi or (211)At. Mice were injected with 2 to 50 muCi on 10 microg or 20 muCi on 2 or 40 microg of 30F11 conjugate. Biodistribution studies showed that the spleen contained the highest concentration of radioactivity, ranging from 167 +/- 23% to 417 +/- 109% injected dose/gram (% ID/g) after injection of the (211)At conjugate and 45 +/- 9% to 166 +/- 11% ID/g after injection of the (213)Bi conjugate. The higher concentrations observed for (211)At-labeled 30F11 were due to its longer half-life, which permitted better localization of isotope to the spleen before decay. (211)At was more effective at producing myelosuppression for the same quantity of injected radioactivity. All mice injected with 20 or 50 muCi (211)At, but none with the same quantities of (213)Bi, had lethal myeloablation. Severe reversible acute hepatic toxicity occurred with 50 muCi (213)Bi, but not with lower doses of (213)Bi or with any dose of (211)At. No renal toxicity occurred with either radionuclide. The data suggest that smaller quantities of (211)At-labeled anti-CD45 antibody are sufficient to achieve myelosuppression and myeloablation with less nonhematologic toxicity compared with (213)Bi-labeled antibody." @default.
• W2023246576 created "2016-06-24" @default.
• W2023246576 creator A5009266851 @default.
• W2023246576 creator A5010225613 @default.
• W2023246576 creator A5026348141 @default.
• W2023246576 creator A5036409687 @default.
• W2023246576 creator A5040412322 @default.
• W2023246576 creator A5076899086 @default.
• W2023246576 creator A5078791373 @default.
• W2023246576 creator A5079519158 @default.
• W2023246576 creator A5084915025 @default.
• W2023246576 creator A5085787488 @default.
• W2023246576 creator A5088957358 @default.
• W2023246576 date "2009-03-15" @default.
• W2023246576 modified "2023-10-18" @default.
• W2023246576 title "Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211" @default.
• W2023246576 cites W1508641049 @default.
• W2023246576 cites W1772206618 @default.
• W2023246576 cites W1986946663 @default.
• W2023246576 cites W2000907432 @default.
• W2023246576 cites W2021090775 @default.
• W2023246576 cites W2033886491 @default.
• W2023246576 cites W2041607504 @default.
• W2023246576 cites W2048412985 @default.
• W2023246576 cites W2059350609 @default.
• W2023246576 cites W2067656235 @default.
• W2023246576 cites W2079078944 @default.
• W2023246576 cites W2079644267 @default.
• W2023246576 cites W2085953840 @default.
• W2023246576 cites W2129834424 @default.
• W2023246576 cites W2158802448 @default.
• W2023246576 cites W2171341874 @default.
• W2023246576 cites W2330413599 @default.
• W2023246576 cites W3022419930 @default.
• W2023246576 cites W4235914577 @default.
• W2023246576 doi "https://doi.org/10.1158/0008-5472.can-08-4363" @default.
• W2023246576 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2657815" @default.
• W2023246576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19244101" @default.
• W2023246576 hasPublicationYear "2009" @default.
• W2023246576 type Work @default.
• W2023246576 sameAs 2023246576 @default.
• W2023246576 citedByCount "46" @default.
• W2023246576 countsByYear W20232465762012 @default.
• W2023246576 countsByYear W20232465762014 @default.
• W2023246576 countsByYear W20232465762015 @default.
• W2023246576 countsByYear W20232465762016 @default.
• W2023246576 countsByYear W20232465762018 @default.
• W2023246576 countsByYear W20232465762019 @default.
• W2023246576 countsByYear W20232465762020 @default.
• W2023246576 countsByYear W20232465762021 @default.
• W2023246576 countsByYear W20232465762022 @default.
• W2023246576 countsByYear W20232465762023 @default.
• W2023246576 crossrefType "journal-article" @default.
• W2023246576 hasAuthorship W2023246576A5009266851 @default.
• W2023246576 hasAuthorship W2023246576A5010225613 @default.
• W2023246576 hasAuthorship W2023246576A5026348141 @default.
• W2023246576 hasAuthorship W2023246576A5036409687 @default.
• W2023246576 hasAuthorship W2023246576A5040412322 @default.
• W2023246576 hasAuthorship W2023246576A5076899086 @default.
• W2023246576 hasAuthorship W2023246576A5078791373 @default.
• W2023246576 hasAuthorship W2023246576A5079519158 @default.
• W2023246576 hasAuthorship W2023246576A5084915025 @default.
• W2023246576 hasAuthorship W2023246576A5085787488 @default.
• W2023246576 hasAuthorship W2023246576A5088957358 @default.
• W2023246576 hasBestOaLocation W20232465761 @default.
• W2023246576 hasConcept C109159458 @default.
• W2023246576 hasConcept C121332964 @default.
• W2023246576 hasConcept C126322002 @default.
• W2023246576 hasConcept C134306372 @default.
• W2023246576 hasConcept C142724271 @default.
• W2023246576 hasConcept C158973077 @default.
• W2023246576 hasConcept C159654299 @default.
• W2023246576 hasConcept C177322064 @default.
• W2023246576 hasConcept C178790620 @default.
• W2023246576 hasConcept C185592680 @default.
• W2023246576 hasConcept C197336794 @default.
• W2023246576 hasConcept C202751555 @default.
• W2023246576 hasConcept C203014093 @default.
• W2023246576 hasConcept C2776146153 @default.
• W2023246576 hasConcept C2777807558 @default.
• W2023246576 hasConcept C2780007613 @default.
• W2023246576 hasConcept C2780931953 @default.
• W2023246576 hasConcept C28328180 @default.
• W2023246576 hasConcept C2911091166 @default.
• W2023246576 hasConcept C29730261 @default.
• W2023246576 hasConcept C2989005 @default.
• W2023246576 hasConcept C33923547 @default.
• W2023246576 hasConcept C542903549 @default.
• W2023246576 hasConcept C54355233 @default.
• W2023246576 hasConcept C55493867 @default.
• W2023246576 hasConcept C62520636 @default.
• W2023246576 hasConcept C71924100 @default.
• W2023246576 hasConcept C86803240 @default.
• W2023246576 hasConcept C98274493 @default.
• W2023246576 hasConceptScore W2023246576C109159458 @default.
• W2023246576 hasConceptScore W2023246576C121332964 @default.
• W2023246576 hasConceptScore W2023246576C126322002 @default.
• W2023246576 hasConceptScore W2023246576C134306372 @default.

• next